Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

57
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/15/2014 09/16/2014 09/17/2014 09/18/2014 09/19/2014 Date
46.75(c) 47.96(c) 48(c) 48.43(c) 47.36(c) Last
2 280 294 3 261 054 2 117 229 3 152 410 6 375 220 Volume
-0.66% +2.59% +0.08% +0.90% -2.21% Change
More quotes
Company
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals.The company operates its business through two segments: Generics & Specialty.The Generics segment primarily develops, manufactures, sells... 
Sector
Pharmaceuticals
Calendar
10/30Earnings Release
Surperformance© rating of Mylan Inc
Trading Rating : Investor Rating :
More about the company
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | MYL | US6285301072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 7 700 M
EBIT 2014 1 968 M
Net income 2014 1 056 M
Debt 2014 7 438 M
Yield 2014 -
Sales 2015 8 564 M
EBIT 2015 2 350 M
Net income 2015 1 597 M
Debt 2015 5 953 M
Yield 2015 -
PER 2014 18,72
PER 2015 13,34
EV / Sales 2014 3,27x
EV / Sales 2015 2,76x
Capitalization 17 715 M
More Financials
Latest news on MYLAN INC
6d ago MYLAN : Commences Phase III Clinical Trials for its Generic Version of Advair Di..
7d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
7d ago MYLAN : Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatmen..
09/10 MYLAN : Launches Generic Boniva® Injection
09/10 MYLAN : to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from ..
09/08 MYLAN : Court Grants Summary Judgment in Favor of Mylan and FDA Related to Gener..
09/05 MYLAN : Launches Generic Boniva® Injection
08/28 MYLAN : ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Fi..
08/28 MYLAN : Acquisitions, Appointments, Patent Grant, Technical Updates, and Awarene..
08/28 MYLAN : Launches Generic Precedex™ Injection - Another Key Product Approva..
08/28 MYLAN : Launches First Generic Klor-Con® Extended-Release Tablets
08/25 MYLAN : Ready2Go(TM) Draft Winners Join Pro Football MVP Adrian Peterson in Educ..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Mylan Inc : Income Statement Evolution
More Financials
EPS Revisions
Mylan Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF